The Cancer Letter (TLC) - Inside information on cancer research and drug development.

Please download the summer issue:

https://cancerletter.com/download/41552/

Persistence, Agility and Cancer Research. The Medicine Mentors podcast with Dr. Wafik El-Diery.

https://themedicinementors.libsyn.com/persistence-agility-cancer-research-with-dr-wafik-el-deiry

Michelle Kossack, PhD, a Postdoctoral Fellow in the Plavicki Lab, received a Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) from the National Institute of Environmental Health Sciences.

Could Rhode Island become the next cancer research hub?

With plans to apply for a NCI designation, a partnership between Brown University and local hospitals could attract funding and patients to Greater Providence.

Below is the link to the article in the Boston Globe:

https://www.bostonglobe.com/2021/07/30/metro/could-rhode-island-become-next-cancer-research-hub/

Great to see Dr. Attila Seyhan in the NY Times Article-Bio Bonds Would Use Wall St. Tools to Fund Medical Research.  

@BrownUCancer, @BrownMedicine, @BrownUResearch, @BrownOncology, #eldeirylab, @BrownPathology, @RIHospital

Tip Pongsuvareeyakul, MD, has completed her 9-month International Visiting Fellowship in Gynecologic Pathology.She has returned to Chiang-Mai University College of Medicine as Assistant Professor of Pathology in July.

Janell A. Carter, MD, PhD, has completed her 2-year pathology research fellowship sponsored by Brown University Department of Pathology & Laboratory Medicine. She was recruited to be the inaugural Division Director of Perinatal Pathology of Phoenix Children’s Hospital in Phoenix, Arizona.

Bassam Aswad, MD, Assistant Professor of Pathology and Laboratory Medicine, Clinician Educator and Dongfen Chen, MD, Instructor in Pathology and Laboratory Medicine, Clinician Educator have been appointed to the faculty at the Providence VA Medical Center.

A new Oncotarget interview with Dr. El-Deiry and a former MD/PhD student in his lab on the paper: "TRAIL receptor agonists convert the response of #breastcancer cells to ONC201 from anti-proliferative to apoptotic." https://youtu.be/nyw1AQl72O4 #eldeirylab

The El-Deiry Lab is thrilled to be working with incredibly talented students, residents, fellows and faculty colleagues at:

@BrownMedicine, @BrownUCancer, @RIHospital, @MiriamHospital, @HasbroChildrens

Our team is making a difference every day here through hard work, resilience, innovation and collaboration.  Please visit the twitter link for further information.

Commentary in Hematology/Oncology on "Liquid biopsy can direct use of EGFR rechallenge in metastatic colorectal cancer," a study presented at the 2021 annual American Society for Clinical Oncology (ASCO) meeting.

Commentary in Hematology/Oncology on "Alrizomadlin may restore efficacy of PD-1 blockade in immunotherapy-resistant tumors," a study presented at the 2021 annual American Society for Clinical Oncology (ASCO) meeting.